14-day Premium Trial Subscription Try For FreeTry Free
Conference Call Scheduled for May 11, 2022 at 4:30 p.m. ET Conference Call Scheduled for May 11, 2022 at 4:30 p.m. ET

ADMA: Pertinent Updates

12:46pm, Monday, 18'th Apr 2022
Institutional ownership has grown in the past 6 months. An activist investor is watching ADMA intently.
Can these penny stocks continue to climb after a bearish trading day? The post Best Penny Stocks to Watch After the Stock Market Takes a Bear Turn appeared first on Penny Stocks to Buy, Picks, News an
Can these penny stocks continue to climb after a bearish trading day? The post Best Penny Stocks to Watch After the Stock Market Takes a Bear Turn appeared first on Penny Stocks to Buy, Picks, News an
RAMSEY, N.J. and BOCA RATON, Fla., April 01, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedica
ADMA reported full-year 2021 numbers on March 24, which disclosed higher than expected revenue, a lower than expected net loss, and strong 2022 guidance.

Top Must-Watch Penny Stocks For Your April List 

08:06pm, Friday, 25'th Mar 2022 PennyStocks
Are these penny stocks on your April watchlist? The post Top Must-Watch Penny Stocks For Your April List  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Are these penny stocks on your April watchlist? The post Top Must-Watch Penny Stocks For Your April List  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Approval of 36-month shelf life encompasses all ASCENIV & BIVIGAM vial sizes, production scales, as well as internal and external fill-finishing
ADMA Biologics Inc (NASDAQ: ADMA) closed a debt refinancing with Hayfin Capital Management of $150 million, and up to an additional $25 million tied to specific revenue targets during 2022. The first

Adma Biologics (ADMA) Reports Q4 Loss, Tops Revenue Estimates

09:35pm, Thursday, 24'th Mar 2022 Zacks Investment Research
Adma Biologics (ADMA) delivered earnings and revenue surprises of 10% and 1.47%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Full Year 2021 Total Revenues of Approximately $81 Million, a 92% Increase Over Full Year 2020
Adma Biologics (ADMA) delivered earnings and revenue surprises of 10% and 1.47%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Conference Call Scheduled for March 24, 2022 at 4:30 p.m. ET Conference Call Scheduled for March 24, 2022 at 4:30 p.m. ET
Conference Call Scheduled for March 24, 2022 at 4:30 p.m. ET Conference Call Scheduled for March 24, 2022 at 4:30 p.m. ET
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE